-Reuters
Smith & Nephew’s Implant Shows 86% Reduction In Re-Tear Rates After Shoulder Surgery
Smith & Nephew plc (NYSE:SNN) announced new data furthering several published studies supporting the use of its REGENETEN Bioinductive Implant in…
Related Posts
Stifel Downgrades Costamare to Hold, Lowers Price Target to $11
Stifel analyst Benjamin Nolan downgrades Costamare (NYSE:CMRE) from Buy to Hold and lowers the price target from $12.5 to $11.
Taiwan Continues Its Crusade Against Chinese Companies For Alleged Poaching Of Chip Engineers
Taiwan officers raided ten Chinese companies or their R&D centers suspected of illegally poaching chip engineers and other…
It’s The Earnings, Stupid
The next big stock market correction has been imminent for, well, months now? Every time the Dow or the Nasdaq rises and falls, more articles admonishing about the inevitable massive stock market 1929-type crash populate investors’ screens.
Generation Investor Should Remain Optimistic